ctDNA-based molecular residual disease and survival in ...
Analysis of 2,240 CRC patients showed ctDNA status post-surgery significantly predicts recurrence and survival. MRD-positive patients had higher recurrence rates and worse DFS and OS than MRD-negative. ctDNA clearance on ACT correlated with better outcomes. MRD status outperformed traditional biomarkers in predicting CRC prognosis.
Reference News
ctDNA-based molecular residual disease and survival in ...
Analysis of 2,240 CRC patients showed ctDNA status post-surgery significantly predicts recurrence and survival. MRD-positive patients had higher recurrence rates and worse DFS and OS than MRD-negative. ctDNA clearance on ACT correlated with better outcomes. MRD status outperformed traditional biomarkers in predicting CRC prognosis.